vs
Healthpeak Properties（DOC）与TRINITY INDUSTRIES INC（TRN）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是TRINITY INDUSTRIES INC的1.2倍（$702.9M vs $611.2M），Healthpeak Properties净利率更高（51.6% vs 31.8%，领先19.9%），TRINITY INDUSTRIES INC同比增速更快（-2.9% vs -6.6%），过去两年Healthpeak Properties的营收复合增速更高（0.5% vs -13.1%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
特里尼蒂工业公司是一家美国工业企业，旗下布局多元业务线，为工业、能源、交通、建筑等核心领域提供适配的产品及相关服务，在多个下游行业拥有稳定的客户基础与业务覆盖。
DOC vs TRN — 直观对比
营收规模更大
DOC
是对方的1.2倍
$611.2M
营收增速更快
TRN
高出3.8%
-6.6%
净利率更高
DOC
高出19.9%
31.8%
两年增速更快
DOC
近两年复合增速
-13.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $611.2M |
| 净利润 | $363.0M | $194.2M |
| 毛利率 | — | 25.5% |
| 营业利润率 | 0.7% | 54.9% |
| 净利率 | 51.6% | 31.8% |
| 营收同比 | -6.6% | -2.9% |
| 净利润同比 | 28.3% | 413.8% |
| 每股收益（稀释后） | $0.28 | $2.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCTRN
| Q1 26 | $702.9M | — | ||
| Q4 25 | $719.4M | $611.2M | ||
| Q3 25 | $705.9M | $454.1M | ||
| Q2 25 | $694.3M | $506.2M | ||
| Q1 25 | $702.9M | $585.4M | ||
| Q4 24 | $698.0M | $629.4M | ||
| Q3 24 | $700.4M | $798.8M | ||
| Q2 24 | $695.5M | $841.4M |
净利润DOCTRN
| Q1 26 | $363.0M | — | ||
| Q4 25 | $114.0M | $194.2M | ||
| Q3 25 | $-117.1M | $30.3M | ||
| Q2 25 | $31.7M | $14.1M | ||
| Q1 25 | $42.8M | $22.1M | ||
| Q4 24 | $4.5M | $37.8M | ||
| Q3 24 | $85.9M | $31.4M | ||
| Q2 24 | $146.0M | $54.4M |
毛利率DOCTRN
| Q1 26 | — | — | ||
| Q4 25 | — | 25.5% | ||
| Q3 25 | 58.6% | 31.1% | ||
| Q2 25 | 60.2% | 26.4% | ||
| Q1 25 | 61.1% | 24.3% | ||
| Q4 24 | 60.3% | 24.6% | ||
| Q3 24 | 60.0% | 21.2% | ||
| Q2 24 | 60.6% | 21.3% |
营业利润率DOCTRN
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | 54.9% | ||
| Q3 25 | 9.2% | 26.1% | ||
| Q2 25 | 5.7% | 18.8% | ||
| Q1 25 | 7.7% | 17.0% | ||
| Q4 24 | -2.2% | 17.8% | ||
| Q3 24 | 14.1% | 15.3% | ||
| Q2 24 | 22.3% | 16.9% |
净利率DOCTRN
| Q1 26 | 51.6% | — | ||
| Q4 25 | 73.2% | 31.8% | ||
| Q3 25 | -16.6% | 6.7% | ||
| Q2 25 | 4.6% | 2.8% | ||
| Q1 25 | 6.1% | 3.8% | ||
| Q4 24 | 0.7% | 6.0% | ||
| Q3 24 | 12.3% | 3.9% | ||
| Q2 24 | 21.0% | 6.5% |
每股收益（稀释后）DOCTRN
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $2.25 | ||
| Q3 25 | $-0.17 | $0.37 | ||
| Q2 25 | $0.05 | $0.17 | ||
| Q1 25 | $0.06 | $0.26 | ||
| Q4 24 | $0.02 | $0.34 | ||
| Q3 24 | $0.12 | $0.37 | ||
| Q2 24 | $0.21 | $0.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $201.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.8B | $1.1B |
| 总资产 | $21.6B | $8.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCTRN
| Q1 26 | $-1.2B | — | ||
| Q4 25 | $467.5M | $201.3M | ||
| Q3 25 | $91.0M | $66.3M | ||
| Q2 25 | $89.4M | $147.7M | ||
| Q1 25 | $70.6M | $94.9M | ||
| Q4 24 | $119.8M | $228.2M | ||
| Q3 24 | $180.4M | $222.4M | ||
| Q2 24 | $106.9M | $257.1M |
总债务DOCTRN
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — |
股东权益DOCTRN
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | $1.1B | ||
| Q3 25 | $7.6B | $1.0B | ||
| Q2 25 | $7.9B | $1.0B | ||
| Q1 25 | $8.2B | $1.1B | ||
| Q4 24 | $8.4B | $1.1B | ||
| Q3 24 | $8.6B | $1.1B | ||
| Q2 24 | $8.8B | $1.1B |
总资产DOCTRN
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | $8.4B | ||
| Q3 25 | $19.6B | $8.9B | ||
| Q2 25 | $19.8B | $8.8B | ||
| Q1 25 | $19.8B | $8.7B | ||
| Q4 24 | $19.9B | $8.8B | ||
| Q3 24 | $20.0B | $8.8B | ||
| Q2 24 | $20.2B | $9.0B |
负债/权益比DOCTRN
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $177.4M |
| 自由现金流经营现金流 - 资本支出 | — | $158.6M |
| 自由现金流率自由现金流/营收 | — | 25.9% |
| 资本支出强度资本支出/营收 | 3.4% | 3.1% |
| 现金转化率经营现金流/净利润 | — | 0.91× |
| 过去12个月自由现金流最近4个季度 | — | $314.1M |
8季度趋势，按日历期对齐
经营现金流DOCTRN
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $177.4M | ||
| Q3 25 | $315.0M | $44.2M | ||
| Q2 25 | $363.5M | $61.6M | ||
| Q1 25 | $279.4M | $76.5M | ||
| Q4 24 | $1.1B | $201.6M | ||
| Q3 24 | $318.2M | $78.5M | ||
| Q2 24 | $316.2M | $241.5M |
自由现金流DOCTRN
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $158.6M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | — | $52.9M | ||
| Q1 25 | — | $67.3M | ||
| Q4 24 | $333.7M | $180.1M | ||
| Q3 24 | — | $62.1M | ||
| Q2 24 | — | $230.2M |
自由现金流率DOCTRN
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | 25.9% | ||
| Q3 25 | — | 7.8% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | 47.8% | 28.6% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 27.4% |
资本支出强度DOCTRN
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | 3.1% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | 105.6% | 3.4% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 1.3% |
现金转化率DOCTRN
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | 0.91× | ||
| Q3 25 | — | 1.46× | ||
| Q2 25 | 11.48× | 4.37× | ||
| Q1 25 | 6.52× | 3.46× | ||
| Q4 24 | 235.43× | 5.33× | ||
| Q3 24 | 3.71× | 2.50× | ||
| Q2 24 | 2.17× | 4.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
TRN
| Manufacturing | $296.5M | 49% |
| Leasing And Management | $234.8M | 38% |
| Maintenance Services Domain | $69.8M | 11% |
| Digital Logistics Services | $11.2M | 2% |
